| Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy Y Tsutani, Y Miyata, H Nakayama, S Okumura, S Adachi, M Yoshimura, ... Chest 145 (1), 66-71, 2014 | 328 | 2014 |
| Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA … Y Tsutani, Y Miyata, H Nakayama, S Okumura, S Adachi, M Yoshimura, ... The Journal of thoracic and cardiovascular surgery 143 (3), 607-612, 2012 | 222 | 2012 |
| Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score–matched analysis in a multicenter study Y Tsutani, Y Miyata, H Nakayama, S Okumura, S Adachi, M Yoshimura, ... The Journal of Thoracic and Cardiovascular Surgery 146 (2), 358-364, 2013 | 209 | 2013 |
| Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of … Y Sanada, K Yoshida, M Ohara, M Oeda, K Konishi, Y Tsutani Pancreas 32 (2), 164-170, 2006 | 181 | 2006 |
| Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection Y Tsutani, Y Miyata, H Nakayama, S Okumura, S Adachi, M Yoshimura, ... The Journal of thoracic and cardiovascular surgery 144 (6), 1365-1371, 2012 | 132 | 2012 |
| Neutrophil elastase induces cell proliferation and migration by the release of TGF-α, PDGF and VEGF in esophageal cell lines Y Wada, K Yoshida, Y Tsutani, H Shigematsu, M Oeda, Y Sanada, ... Oncology reports 17 (1), 161-167, 2007 | 127 | 2007 |
| Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution … Y Tsutani, Y Miyata, T Yamanaka, H Nakayama, S Okumura, S Adachi, ... The Journal of thoracic and cardiovascular surgery 146 (1), 17-23, 2013 | 116 | 2013 |
| Prognostic impact of a ground-glass opacity component in clinical stage IA non–small cell lung cancer A Hattori, K Suzuki, K Takamochi, M Wakabayashi, K Aokage, H Saji, ... The Journal of Thoracic and Cardiovascular Surgery 161 (4), 1469-1480, 2021 | 112 | 2021 |
| The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma Y Tsutani, Y Miyata, T Mimae, K Kushitani, Y Takeshima, M Yoshimura, ... The Journal of thoracic and cardiovascular surgery 146 (3), 580-585, 2013 | 96 | 2013 |
| Pre-existing interstitial lung abnormalities are risk factors for immune checkpoint inhibitor-induced interstitial lung disease in non-small cell lung cancer Y Nakanishi, T Masuda, K Yamaguchi, S Sakamoto, Y Horimasu, ... Respiratory Investigation 57 (5), 451-459, 2019 | 95 | 2019 |
| Surgical outcomes of complex versus simple segmentectomy for stage I non-small cell lung cancer Y Handa, Y Tsutani, T Mimae, T Tasaki, Y Miyata, M Okada The Annals of thoracic surgery 107 (4), 1032-1039, 2019 | 89 | 2019 |
| Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma H Uehara, Y Tsutani, S Okumura, H Nakayama, S Adachi, M Yoshimura, ... The Annals of Thoracic Surgery 96 (6), 1958-1965, 2013 | 79 | 2013 |
| Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory … K Aokage, K Suzuki, H Saji, M Wakabayashi, T Kataoka, Y Sekino, ... The Lancet Respiratory Medicine 11 (6), 540-549, 2023 | 76 | 2023 |
| Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer S Watanabe, K Nakagawa, K Suzuki, K Takamochi, H Ito, J Okami, ... Japanese journal of clinical oncology 47 (12), 1112-1118, 2017 | 75 | 2017 |
| Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages T Mimae, M Okada, M Hagiyama, Y Miyata, Y Tsutani, T Inoue, ... Clinical Cancer Research 18 (4), 945-955, 2012 | 74 | 2012 |
| Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer Y Handa, Y Tsutani, T Mimae, Y Miyata, M Okada European Journal of Cardio-Thoracic Surgery 57 (1), 114-121, 2020 | 71 | 2020 |
| Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma and squamous cell … Y Tsutani, Y Miyata, K Misumi, T Ikeda, T Mimura, J Hihara, M Okada Japanese journal of clinical oncology 41 (7), 890-896, 2011 | 64 | 2011 |
| Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma M Okada, T Mimae, Y Tsutani, H Nakayama, S Okumura, M Yoshimura, ... Annals of cardiothoracic surgery 3 (2), 153, 2014 | 63 | 2014 |
| Radical hybrid video-assisted thoracic segmentectomy: long-term results of minimally invasive anatomical sublobar resection for treating lung cancer M Okada, Y Tsutani, T Ikeda, K Misumi, K Matsumoto, M Yoshimura, ... Interactive cardiovascular and thoracic surgery 14 (1), 5-11, 2012 | 60 | 2012 |
| Prognostic role of subtype classification in small-sized pathologic N0 invasive lung adenocarcinoma T Yoshiya, T Mimae, Y Tsutani, N Tsubokawa, S Sasada, Y Miyata, ... The Annals of Thoracic Surgery 102 (5), 1668-1673, 2016 | 52 | 2016 |
Yukio TakeshimaHiroshima University在 hiroshima-u.ac.jp 的电子邮件经过验证
